Hydrocortisone Strides Pharma Uk (Hydrocortisone)

Hydrocortisone Strides Pharma Uk is indicated for the topical management of mild to moderate inflammatory skin conditions.

• Relief of mild eczema and atopic dermatitis symptoms.
• Treatment of irritant or allergic contact dermatitis.
• Reduction of redness and swelling associated with insect bites or minor burns.
• Management of localized psoriasis plaques.
• Soothing of superficial skin inflammation caused by rashes.
• Adjunctive use for soothing skin irritation after minor surgical procedures.

• Hydrocortisone exerts its anti‑inflammatory effect by binding to intracellular glucocorticoid receptors. The receptor‑ligand complex translocates to the nucleus where it modulates gene transcription, suppressing pro‑inflammatory cytokines such as interleukin‑1, interleukin‑6, and tumor necrosis factor‑α. It also induces the synthesis of anti‑inflammatory proteins like annexin‑1, leading to reduced leukocyte migration and vascular permeability in the skin. These actions collectively decrease edema, erythema, and pruritus at the site of application.

Topical hydrocortisone may cause local skin reactions, although many users experience no adverse effects.

Common

• Mild burning or stinging sensation at the application site.
• Transient itching or dryness of the skin.
• Slight redness or irritation that resolves within days.
• Temporary discoloration or hyperpigmentation of the treated skin.
• Mild swelling or edema at the site of application.

Serious

• Development of skin atrophy or thinning with prolonged use.
• Allergic contact dermatitis manifesting as rash, swelling, or vesicles.
• Secondary infection of the treated area.
• Systemic absorption leading to hypothalamic‑pituitary‑adrenal (HPA) axis suppression, especially when applied over large areas.
• Delayed wound healing or increased risk of ulceration in compromised skin.

When using Hydrocortisone Strides Pharma Uk, certain precautions help minimize risks and ensure safe application.

• Avoid applying to broken, infected, or ulcerated skin unless directed by a healthcare professional.
• Limit use to the prescribed area and duration, typically not exceeding two weeks without review.
• Do not use under occlusive dressings unless advised, as this can increase absorption.
• Keep the product away from eyes, mucous membranes, and genital regions.
• Discontinue use and seek medical advice if signs of irritation or allergic reaction develop.
• Pregnant or breastfeeding individuals should consult a clinician before use.
• Children may be more susceptible to systemic effects; use the lowest effective amount.

Topical hydrocortisone can interact with other skin products or systemic medications, influencing its efficacy or safety.

Avoid

• Concurrent use of other potent topical corticosteroids on the same area, which may increase risk of skin atrophy.
• Application over large body surface areas combined with systemic glucocorticoids, raising the chance of systemic side effects.
• Do not use with topical antibiotics containing sulfonamides if patient has known sulfa allergy.

Use with caution

• Combining with topical calcineurin inhibitors; monitor for increased irritation.
• Use alongside antiviral or antifungal creams; assess for potential reduced effectiveness of the hydrocortisone.
• Applying over areas treated with retinoids; may enhance skin irritation.